Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, October 28 at 2:00 PM ET

Register Free →

This Government Contract opportunity from Department Of Health And Human Services was posted on July 14, 2025. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

OPTICAL INSTRUMENTS

Closed
NIHOLAOOA3NOIA71425Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 325414
Federal
Foot and Mouth Disease (FMD) Vaccine Antigen Concentrate (VAC)
Solicitation # 12639527R0001
Solicitation 12639527R0001 is a request for proposals issued by the USDA Animal and Plant Health Inspection Service (APHIS) for an Indefinite Delivery Indefinite Quantity (IDIQ) contract. The requirement covers the purchase, storage, and production of Foot and Mouth Disease (FMD) Vaccine Antigen Concentrate (VAC), the conversion of Government-owned VAC into usable finished vaccines, and the direct purchase of finished vaccines. The contract has a ceiling price of 800 million dollars and a long-term performance horizon, featuring five one-year ordering periods starting approximately December 1, 2026, with conversion and delivery of finished vaccines extending through November 30, 2044. The scope of work requires the contractor to produce VAC capable of yielding at least 1.0 million doses and maintain these materials on their premises under strict quality control and temperature standards. Because live FMDV is a Tier 1 Select Agent, the contractor must hold a select agent authorization issued by CDC/APHIS. Finished vaccines must be packaged to maintain temperatures between 2 to 8 degrees Celsius for 24 hours and include electronic temperature monitors. Award will be based on the most advantageous offer considering technical capability, past performance from the last five years, and fair and reasonable pricing. Proposals must be submitted electronically to Stephen Tees by November 10, 2026, at 1700 CT, organized into four separate volumes.
Mrpbs Minneapolis Mn

POSTED

20 days ago

DEADLINE

in 21 days

General Info

NAICS

325414 - Biological Product (except Diagnostic) Manufacturing

Place of Performance

Bethesda, MD, 20892, USA

Set-Aside

NONE

Documents

1

NIH Notice of Intent to Sole Source - Optical Instruments (OLA003NOLA71425)

PDF, High priority: read this firstsources-sought
High

AI Contract Breakdown

Uniform Contract Format

Contract not broken down yet

CLEATUS splits the solicitation into Uniform Contract Format (UCF) sections: scope, pricing, deliverables, and evaluation criteria.

Timeline

PhaseClosed
Posted

special-notice

Response Deadline

Deadline has passed

Submission Closed

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyDepartment Of Health And Human Services → National Institutes Of Health Olao
Contacts2 people available
OfficeBETHESDA, MD, 20892, USA
Office AddressBETHESDA, MD, 20892, USA
Contacts
Zobair Qasimzadah
Sharmaine Fagan

Full Description

Show more
NOTICE OF INTENT TO SOLE SOURCE NIH OLAOOA3NOIA71425 OPTICAL INSTRUMENTS, The National Institutes of Health's Office of Acquisition on behalf of the NIH Supply Center intends to negotiate on a sole source basis with - LIFE TECHNOLOGIES CORPORATION for the products listed in the specifications doc below. It is anticipated that an award will be issued approximately Five (5) after the date of this notice unless the Government determines that another supplier has the capability to meet this requirement. Response The proposed acquisition action is for items and services for which the Government intends to solicit and negotiate with only one source under the authority of FAR 13.106-1 (b). If you believe you can provide the items or services requested, responsible sources may submit a capability statement, which shall be considered by the agency. Please send to the attention of Zobair Qasim zadah, Contract Specialist/NIH referencing notice number NIH-OLAO-OA3-NOI-7.9.25 by 7.14.25 @10:00A.M. A determination by the Government not to compete this proposed contract acquisition based upon responses to the notice is solely within the discretion of the Government. Information received will normally be considered solely for the purpose of determining whether to conduct a competitive procurement. This notice does not obligate the Government to award a contract or otherwise pay for the information provided in response. The Government reserves the right to use information provided by respondents for any purpose deemed necessary and legally appropriate. Any organization responding to this notice should ensure that its response is complete and sufficiently detailed. Information provided will be used to assess tradeoffs and alternatives available for the potential requirement and may lead to the development of a solicitation. Respondents are advised that the Government is under no obligation to acknowledge receipt of the information received or provide feedback to respondents with respect to any information submitted. Any solicitation resulting from the analysis of information obtained will be announced to the public on SAM.gov in accordance with the FAR Part 5. However, responses to this notice will not be considered adequate responses to a solicitation. No proprietary, classified, confidential, or sensitive information should be included in your response. The Government reserves the right to use any non-proprietary technical information in any resultant solicitation(s). Statement of Work Scope and Tasks: The contractor shall supply following: Products: Invitrogen EVOS Light Cube Starter Kit, DAPI, GFP, Texas Red, Description: DAPI, GFP, and Texas Red Light Cubes, For Use With: DAPI/GFP/Texas Red, For Use With: EVOS Imaging Systems, Includes: Condensing Optics, Hard-coated Filters, Quantity: 3 Total Cubes/Kit, Product Line: EVOS Vendor Catalog # AMEP5016 Hazardous Material 1 Invitrogen Celleste 6 Image Analysis Software, For Use With: EVOS, Quantity: 1 each Vendor Catalog # AMEP4942 This item is being sold as 1 per each Open Market 1 Invitrogen Celleste 5.0 3D Blind/Non-Blind Deconvolution Module, Description: For use with EVOS, Includes: 1 Card Vendor Catalog # AMEP4865 This item is being sold as 1 per each Open Market 1 Invitrogen Celleste 3D Analysis Module, single-user license, For Use With: EVOS, Quantity: 1 card, Shipping Condition: Room Temperature, Product Line: Invitrogen Vendor Catalog # AMEP4867 Hazardous Material Shelf Life 1Y This item is being sold as 1 per each Open Market Original Catalog Number AMEP4867 1 Vendor Catalog # AMEP4876 Hazardous Material Open Market Original Catalog Number AMEP4876 1 Place of Performance NIH Technical evaluation criteria example: Quote Evaluation Process Lowest Price Technically Acceptable

More opportunities from Department Of Health And Human Services → National Institutes Of Health Olao

Same awarding agency

NAICS: 541614
New
Federal
R--RADx Coordination Center Notice of Intent
Solicitation # 75N98026R00176
The National Institute of Biomedical Imaging and Bioengineering (NIBIB) has issued a Notice of Intent under solicitation 75N98026R00176 to award a non-competitive modification to IDIQ Contract No. 75N92022D00014. This modification intends to increase the contract ceiling for the Massachusetts General Hospital Consortia for Improving Medicine with Innovation and Technology (CIMIT) to support the Rapid Acceleration of Diagnostics (RADx-Tech) initiative. The initiative operates as an innovation funnel to accelerate the development, commercialization, and implementation of health technologies through a collaborative network consisting of a Coordination Center for operational oversight and workflows, a Commercialization Center for subject matter expert selection, and a Validation Center for technical and clinical verification. The government anticipates issuing the modification around December 2026. While this is a non-competitive intent, interested parties may submit capability statements via email to the contracting officer, Melanie Suarez, or contract specialist, Noelle Decenzo, by November 2, 2026. Submissions must reference the notice number and include details regarding employee count, professional qualifications of technical personnel, available facilities and equipment, and an outline of similar previous research projects. All responding parties must maintain an active registration in the System for Award Management (SAM).
Process, Physical Distribution, and Logistics Consulting Services

POSTED

5 days ago

DEADLINE

in 12 days
View Details

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS